Clinical Trial Update: The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) [NA]

View source ↗

Summary

Clinical trial update on ranolazine effects in ischemic cardiomyopathy patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Cardiovascular Institute of the South Clinical Research Corporation | Conditions: Cardiomyopathy | NA | Status: TERMINATED | Results posted: 2020-02-18